Literature DB >> 24075297

Prehospital use of inhaled steroids and incidence of acute lung injury among patients at risk.

Emir Festic1, Enrique Ortiz-Diaz, Augustine Lee, Guangxi Li, Daryl J Kor, Adesanya Adebola, Ozan Akca, Jason Hoth, Joseph E Levitt, Rickey Carter, Ognjen Gajic.   

Abstract

PURPOSE: Inhaled corticosteroids (ICSs) attenuated lung injury in animal studies. We investigated the association between prehospital ICS and incidence of acute lung injury (ALI) among patients at risk.
METHODS: In this ancillary analysis of the large multicenter Lung Injury Prediction Study cohort, we developed a propensity score for prehospital ICS use followed by matching, for all patients and for a subgroup of patients with at least 1 risk factor for direct pulmonary injury. The primary outcome was ALI; secondary outcomes included acute respiratory distress syndrome, need for invasive mechanical ventilation, and hospital mortality.
RESULTS: Of the 5126 patients, 401 (8%) were using ICS. Acute lung injury developed in 343 (7%). The unadjusted incidence of ALI was 4.7% vs 6.9% (P = .12) among those in ICS compared with non-ICS group. In the "direct" lung injury subgroup, the unadjusted incidence of ALI was 4.1% vs 10.6% (P = 0.006). After propensity matching, the estimated effect for ALI in the whole cohort was 0.69 (95% confidence interval, 0.39-1.2; P = .18), and that in the direct subgroup was 0.56 (95% confidence interval, 0.22-1.46; P = .24).
CONCLUSIONS: Preadmission use of ICS in a hospitalized population of patients at risk for ALI was not significantly associated with a lower incidence of ALI once controlled by comprehensive propensity-matched analysis.
© 2013.

Entities:  

Keywords:  Acute lung injury; Acute respiratory distress syndrome; Corticosteroids; Inhaled steroids

Mesh:

Substances:

Year:  2013        PMID: 24075297      PMCID: PMC4219561          DOI: 10.1016/j.jcrc.2013.08.011

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  29 in total

1.  Pulmonary granulocyte accumulation is reduced by nebulized corticosteroid in septic pigs.

Authors:  S Walther; I Jansson; S Berg; S Lennquist
Journal:  Acta Anaesthesiol Scand       Date:  1992-10       Impact factor: 2.105

2.  Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome.

Authors:  Kenneth P Steinberg; Leonard D Hudson; Richard B Goodman; Catherine Lee Hough; Paul N Lanken; Robert Hyzy; B Taylor Thompson; Marek Ancukiewicz
Journal:  N Engl J Med       Date:  2006-04-20       Impact factor: 91.245

3.  Effects of budesonide and N-acetylcysteine on acute lung hyperinflation, inflammation and injury in rats.

Authors:  Anne-Helene Jansson; Christina Eriksson; Xiangdong Wang
Journal:  Vascul Pharmacol       Date:  2005-08       Impact factor: 5.773

4.  Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group.

Authors:  R B D'Agostino
Journal:  Stat Med       Date:  1998-10-15       Impact factor: 2.373

5.  Established acute respiratory distress syndrome: benefit of corticosteroid rescue therapy.

Authors:  J B Keel; M Hauser; R Stocker; P C Baumann; R Speich
Journal:  Respiration       Date:  1998       Impact factor: 3.580

Review 6.  Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome.

Authors:  Magda Cepkova; Michael A Matthay
Journal:  J Intensive Care Med       Date:  2006 May-Jun       Impact factor: 3.510

Review 7.  Epidemiology and outcomes of acute lung injury.

Authors:  Gordon D Rubenfeld; Margaret S Herridge
Journal:  Chest       Date:  2007-02       Impact factor: 9.410

8.  Corticosteroid by aerosol in septic pigs--effects on pulmonary function and oxygen transport.

Authors:  S Walther; I Jansson; S Berg; L Olsson Rex; S Lennquist
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

9.  Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial.

Authors:  G Umberto Meduri; Emmel Golden; Amado X Freire; Edwin Taylor; Muhammad Zaman; Stephanie J Carson; Mary Gibson; Reba Umberger
Journal:  Chest       Date:  2007-04       Impact factor: 9.410

10.  Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial.

Authors:  G U Meduri; A S Headley; E Golden; S J Carson; R A Umberger; T Kelso; E A Tolley
Journal:  JAMA       Date:  1998-07-08       Impact factor: 56.272

View more
  7 in total

Review 1.  The mercurial nature of neutrophils: still an enigma in ARDS?

Authors:  Andrew E Williams; Rachel C Chambers
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-12-06       Impact factor: 5.464

Review 2.  Emerging therapies for the prevention of acute respiratory distress syndrome.

Authors:  Carl A Ruthman; Emir Festic
Journal:  Ther Adv Respir Dis       Date:  2015-05-22       Impact factor: 4.031

Review 3.  Incident pneumonia and mortality in patients with chronic obstructive pulmonary disease. A double effect of inhaled corticosteroids?

Authors:  Emir Festic; Paul D Scanlon
Journal:  Am J Respir Crit Care Med       Date:  2015-01-15       Impact factor: 21.405

4.  Randomized Clinical Trial of a Combination of an Inhaled Corticosteroid and Beta Agonist in Patients at Risk of Developing the Acute Respiratory Distress Syndrome.

Authors:  Emir Festic; Gordon E Carr; Rodrigo Cartin-Ceba; Richard F Hinds; Valerie Banner-Goodspeed; Vikas Bansal; Adijat T Asuni; Daniel Talmor; Govindarajan Rajagopalan; Ryan D Frank; Ognjen Gajic; Michael A Matthay; Joseph E Levitt
Journal:  Crit Care Med       Date:  2017-05       Impact factor: 7.598

5.  Preadmission Oral Corticosteroids Are Associated With Reduced Risk of Acute Respiratory Distress Syndrome in Critically Ill Adults With Sepsis.

Authors:  Andrew C McKown; Erin M McGuinn; Lorraine B Ware; Li Wang; David R Janz; Todd W Rice; Matthew W Semler
Journal:  Crit Care Med       Date:  2017-05       Impact factor: 7.598

6.  Rationale and design of a prospective, multicentre, randomised, conventional treatment-controlled, parallel-group trial to evaluate the efficacy and safety of ulinastatin in preventing acute respiratory distress syndrome in high-risk patients.

Authors:  Zongyu Wang; Liyuan Tao; Yingying Yan; Xi Zhu
Journal:  BMJ Open       Date:  2019-03-07       Impact factor: 2.692

7.  Early identification of patients at risk for acute respiratory distress syndrome among severe pneumonia: a retrospective cohort study.

Authors:  Jian Luo; He Yu; Yue-Hong Hu; Dan Liu; Yi-Wei Wang; Mao-Yun Wang; Bin-Miao Liang; Zong-An Liang
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.